These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants. Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854 [TBL] [Abstract][Full Text] [Related]
25. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction). Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717 [TBL] [Abstract][Full Text] [Related]
26. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment. Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893 [TBL] [Abstract][Full Text] [Related]
27. Scintigraphic evaluation of functional renal reserve using angiotensin-converting enzyme inhibition in patients with type II diabetes mellitus. Erbas B; Erbas T; Akalin S; Varoglu E; Koray Z; Bekdik CF Am J Nephrol; 1993; 13(3):203-9. PubMed ID: 8213932 [TBL] [Abstract][Full Text] [Related]
28. Proteinuria-lowering effect of heparin therapy in diabetic nephropathy without affecting the renin-angiotensin-aldosterone system. Benck U; Haeckel S; Clorius JH; van der Woude FJ Clin J Am Soc Nephrol; 2007 Jan; 2(1):58-67. PubMed ID: 17699388 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system. Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690 [TBL] [Abstract][Full Text] [Related]
30. Minimization of indomethacin-induced reduction in renal function by misoprostol. Weir MR; Klassen DK; Hall PS; Schubert C; Voss TE; Stromatt SC; Brown JA J Clin Pharmacol; 1991 Aug; 31(8):729-35. PubMed ID: 1908864 [TBL] [Abstract][Full Text] [Related]
31. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358 [TBL] [Abstract][Full Text] [Related]
34. Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. ter Wee PM; Smit AJ; Rosman JB; Sluiter WJ; Donker AJ Am J Nephrol; 1986; 6(1):42-6. PubMed ID: 3963058 [TBL] [Abstract][Full Text] [Related]
35. Effect of acetylsalicylic acid on renal function in systemic lupus erythematosus. Rasmussen S; Petersen J; Nielsen IL; Christensen P; Hilden T Eur J Clin Pharmacol; 1982; 23(6):505-8. PubMed ID: 7160418 [TBL] [Abstract][Full Text] [Related]
36. Control of plasma renin activity in chronic stable renal disease. Kahn T; Mohammad G; Bornia ME; Stein RM; Krakoff LR J Lab Clin Med; 1975 Apr; 85(4):637-44. PubMed ID: 1120931 [TBL] [Abstract][Full Text] [Related]
37. Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome. Alayoud A; Qamouss O; Hamzi A; Benyahia M; Oualim Z Arab J Nephrol Transplant; 2012 Sep; 5(3):153-7. PubMed ID: 22967254 [TBL] [Abstract][Full Text] [Related]
38. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229 [TBL] [Abstract][Full Text] [Related]
39. Treatment of the nephrotic syndrome with indomethacin. Donker AJ; Brentjens JR; van der Hem GK; Arisz L Nephron; 1978; 22(4-6):374-81. PubMed ID: 740100 [TBL] [Abstract][Full Text] [Related]
40. Enhanced plasma endothelin in healthy uninephrectomized subjects during basal conditions and after indomethacin. Nielsen CB; Sørensen SS; Pedersen EB Nephrol Dial Transplant; 1994; 9(1):5-9. PubMed ID: 8177477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]